Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (9) , 1914-1924.e6
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR2127, BO1573, HE2458/18, HE2458/14, AR 781/1-2)
- Deutsche Krebshilfe
- Deutsche Stiftung Sklerodermie
- Deutsche Forschungsgemeinschaft
This publication has 52 references indexed in Scilit:
- Cold Atmospheric Plasma (CAP) Changes Gene Expression of Key Molecules of the Wound Healing Machinery and Improves Wound Healing In Vitro and In VivoPLOS ONE, 2013
- Fussel-15, a New Player in Wound Healing, Is Deregulated in Keloid and Localized SclerodermaThe American Journal of Pathology, 2011
- Loss of Endogenous Bone Morphogenetic Protein-6 Aggravates Renal FibrosisThe American Journal of Pathology, 2011
- Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healingEMBO Reports, 2010
- Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progressionThe Journal of Pathology, 2009
- BMP-7 Does Not Protect against Bleomycin-Induced Lung or Skin FibrosisPLOS ONE, 2008
- Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in ratsGut, 2007
- Transforming Growth Factor-β Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3Journal of Biological Chemistry, 2001
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999